Acumen Pharmaceuticals (ABOS) Net Cash Flow Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 53.46% |
| 10 | Acumen Pharmaceuticals | 164.37 Mn | 35.97 Mn | - | 59.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.89% |
| Dec 31, 2025 | 193.40% |
| Sep 30, 2025 | 128.82% |
| Jun 30, 2025 | -68.37% |
| Mar 31, 2025 | 72.60% |
| Dec 31, 2024 | 108.71% |
| Sep 30, 2024 | -294.70% |
| Jun 30, 2024 | 2,899.73% |
| Mar 31, 2024 | 61.70% |
| Dec 31, 2023 | -2.00% |
| Sep 30, 2023 | -61.57% |
| Jun 30, 2023 | -132.41% |
| Mar 31, 2023 | -288.88% |
| Dec 31, 2022 | -101.17% |
| Sep 30, 2022 | -30.63% |
| Jun 30, 2022 | 154.34% |
| Mar 31, 2022 | -465.32% |
| Dec 31, 2021 | -377.42% |
| Sep 30, 2021 | 5,321.36% |